The pharmaceutical industry operates within an environment of intense competition and substantial financial risk, where the journey of a new […]
Navigating the Minefield: Critical Mistakes to Avoid During a Pharmaceutical Drug Launch Read Post »
I. Executive Summary The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act,
The Transformation of the US Generic Drug Industry After the Hatch-Waxman Act of 1984 Read Post »
Identifying Potential Generic Drug Entrants Before FDA Approval Section 1: Introduction: The Strategic Importance of Early Generic Entrant Identification. The
Customer Success: How do we identify generic entrants before they get FDA approval? Read Post »
The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very
DrugPatentWatch Headlines Swissbiotech Annual Report Read Post »
Pharmaceutical innovation stands as a cornerstone of progress in healthcare, a dynamic field characterized by a continuous cycle of discovery
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection Read Post »
Get fresh news and insights, drug patent expirations & more…
